TABLE 2.
Analyte | Panther Fusion |
eSensor |
Lyraa |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
PPA |
NPA |
PPA |
NPA |
PPA |
NPA |
|||||||
No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | |
Flu A | 15/15 | 100 (79.6 −100) | 89/89 | 100 (95.9–100) | 15/15 | 100 (79.6–100) | 89/90 | 98.9 (94–99.8) | 15/15 | 100 (79.6–100) | 89/89 | 100 (95.9–100) |
Flu B | 2/2 | 100 (34.2–100) | 102/102 | 100 (96.4–100) | 2/2 | 100 (34.2–100) | 102/102 | 100 (96.4–100) | 1/2 | 50 (9.5–90.6) | 102/102 | 100 (96.4–100) |
RSV | 11/11 | 100 (74.1–100) | 93/93 | 100 (96–100) | 11/11 | 100 (74.1–100) | 93/94 | 98.9 (94.2–99.8) | 8/11 | 72.7 (43.4–90.3) | 93/93 | 100 (96–100) |
Para 1–3 | 4/4 | 100 (51–100) | 100/100 | 100 (96.3–100) | 4/4 | 100 (51–100) | 100/102 | 98 (93–99.4) | 2/4 | 50 (15–85) | 100/100 | 100 (96.3–100) |
hMPV | 6/6 | 100 (61–100) | 98/102 | 96.1 (90–98.4) | 6/6 | 100 (61–100) | 98/99 | 98.9 (94.4–99.8) | 4/6 | 66.7 (30–90.3) | 98/98 | 100 (96.2–100) |
Adeno | 5/5 | 100 (56.6–100) | 99/99 | 100 (96.3–100) | 5/5 | 100 (56.6–100) | 99/99 | 100 (96.3–100) | 5/5 | 100 (56.6–100) | 99/100 | 98.9 (94.5–99.8) |
RV | 27/27 | 100 (87.5–100) | 77/77 | 100 (95.3–100) | 27/27 | 100 (87.5–100) | 77/97 | 79.4 (63.3–82.5) |
The Lyra assay does not test for the RV target.